Crossmark

Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial

Crossref DOI link: https://doi.org/10.1245/s10434-020-08743-9

Published Online: 2020-06-22

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lurvink, Robin J.

Tajzai, Rudaba

Rovers, Koen P.

Wassenaar, Emma C. E.

Moes, Dirk-Jan A. R.

Pluimakers, Giulia

Boerma, Djamila

Burger, Jacobus W. A.

Nienhuijs, Simon W.

de Hingh, Ignace H. J. T.

Deenen, Maarten J.
Funding

Funding for this research was provided by:

Catharina Research Foundation (2017-5)

St. Antonius Research Foundation (17.4)
License Information

Text and Data Mining valid from 2020-06-22

Version of Record valid from 2020-06-22
More Information

Article History

Received: 2 April 2020

First Online: 22 June 2020

Disclosure

: None to declare.

Document is current

Any future updates will be listed below